The Goldman Sachs Group Cuts Teladoc Health (NYSE:TDOC) Price Target to $10.00

Teladoc Health (NYSE:TDOC) had its price target lowered by The Goldman Sachs Group from $13.00 to $10.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the health services provider’s stock.

TDOC has been the topic of a number of other reports. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Evercore ISI reduced their price target on shares of Teladoc Health from $8.00 to $7.00 and set an “in-line” rating on the stock in a research report on Thursday. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday. Jefferies Financial Group cut their target price on Teladoc Health from $10.00 to $8.00 and set a “hold” rating for the company in a research note on Monday, April 21st. Finally, Citigroup decreased their price target on Teladoc Health from $11.00 to $8.75 and set a “neutral” rating on the stock in a research note on Friday, April 25th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $9.81.

Teladoc Health Trading Up 1.1 %

Shares of Teladoc Health stock opened at $7.07 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock’s 50 day simple moving average is $8.02 and its 200-day simple moving average is $9.49. The stock has a market cap of $1.24 billion, a P/E ratio of -1.23 and a beta of 1.73. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.58% of the company’s stock.

Institutional Trading of Teladoc Health

A number of institutional investors have recently bought and sold shares of TDOC. Victory Capital Management Inc. lifted its position in shares of Teladoc Health by 1,037.5% during the 1st quarter. Victory Capital Management Inc. now owns 237,135 shares of the health services provider’s stock worth $1,888,000 after buying an additional 216,288 shares during the last quarter. Cerity Partners LLC grew its position in shares of Teladoc Health by 118.8% in the 1st quarter. Cerity Partners LLC now owns 25,123 shares of the health services provider’s stock valued at $200,000 after buying an additional 13,642 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in Teladoc Health during the 1st quarter worth $200,000. Summit Trail Advisors LLC lifted its position in Teladoc Health by 77.0% in the first quarter. Summit Trail Advisors LLC now owns 17,978 shares of the health services provider’s stock valued at $143,000 after acquiring an additional 7,819 shares during the last quarter. Finally, Vontobel Holding Ltd. boosted its stake in Teladoc Health by 61.4% in the first quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider’s stock valued at $171,000 after acquiring an additional 8,152 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.